Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002419456 | SCV002678199 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-09-08 | criteria provided, single submitter | clinical testing | The p.P2700S variant (also known as c.8098C>T), located in coding exon 64 of the FBN1 gene, results from a C to T substitution at nucleotide position 8098. The proline at codon 2700 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003481294 | SCV004227411 | uncertain significance | not provided | 2022-07-12 | criteria provided, single submitter | clinical testing | BP4, PP2 |
Labcorp Genetics |
RCV003776479 | SCV004568889 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-07-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004005765 | SCV004827213 | uncertain significance | Marfan syndrome | 2023-06-28 | criteria provided, single submitter | clinical testing |